Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

ClinicalTrials.gov ID: NCT05568706

Public ClinicalTrials.gov record NCT05568706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults With Acute Respiratory Syncytial Virus Infection Who Are at High Risk for Complications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who were at high risk for complications after RSV infection.

Study identification

NCT ID
NCT05568706
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Enanta Pharmaceuticals, Inc
Industry
Enrollment
187 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2022 (Actual)
Primary completion
Jun 23, 2025 (Actual)
Completion
Jun 23, 2025 (Actual)
Last update posted
Aug 19, 2026

2022 – 2025

United States locations

U.S. sites
31
U.S. states
13
U.S. cities
29
Facility City State ZIP Site status
Voyage Medical Tempe Arizona 85282-2455 —
UCSF Fresno Fresno California 93701 —
Torrance Clinical Research Institute Lomita California 90717 —
Downtown LA Research Center Inc - ClinEdge - PPDS Los Angeles California 90017 —
Allianz Research Institute Inc Westminster California 92683 —
Allianz Research Institute - Colorado Aurora Colorado 80014 —
Bay Pines VA Healthcare System Bay Pines Florida 33744 —
C&A Clinical Trials Corp Cape Coral Florida 33990 —
Beautiful Minds Clinical Research Center Cutler Bay Florida 33157 —
Dinamo Research & Diagnostic center, LLC Hialeah Florida 33015 —
I.H.S Health LLC Kissimmee Florida 34741 —
Dynamic Medical Research, LLC Miami Florida 33144 —
Floridian Research Institute Miami Florida 33179-2537 —
Orlando VA Healthcare System Orlando Florida 32827 —
Ormond Beach Clinical Research Ormond Beach Florida 32174 —
CDC Research Institute, LLC Port Saint Lucie Florida 34952 —
Research Bay, Inc. Tampa Florida 33607 —
Santos Research Center Tampa Florida 33615 —
Covenant Pulmonary Criticial Care and Research Ins East Point Georgia 30344 —
Snake River Research Idaho Falls Idaho 83404 —
University of Louisville Louisville Kentucky 40202 —
Mercury Street Medical Butte Montana 59701 —
Global Health Institute Syracuse New York 13210-1685 —
Progressive Medicine of the Triad, LLC Winston-Salem North Carolina 27103 —
Toledo Institute of Clinical Research Toledo Ohio 43617 —
IMA Clinical Research - Austin - PPDS Austin Texas 78704-7507 —
Valley Institute of Research Fort Worth Texas 76164-9041 —
HDH Research, Inc. Houston Texas 77022 —
Metroplex Pulmonary and Sleep Medicine Center-4833 Medical Center Dr Unit 6B McKinney Texas 75069 —
SMS Clinical Research, LLC Mesquite Texas 75149 —
Eastside Research Associates Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05568706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05568706 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →